Revvity has introduced Signals BioDesign™, a cloud based molecular cloning platform that supports construct design and sequencing analysis in biologics research. The system brings Golden Gate, Gibson assembly, restriction/ligation, primer design, Sanger sequencing analysis, and protein translation into a single environment, enabling teams to design and manage large numbers of constructs with shared data. Integration with the Signals One platform connects cloning design to existing bioregistration and multi-modal experiment capture, supporting coordinated workflows across biotech and pharmaceutical R&D groups.